Publications by authors named "Max E Hallin"

Claim this Profile
N
Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
Dana D Hu-Lowe, Helen Y Zou, Maren L Grazzini, Max E Hallin, Grant R Wickman

Clin Cancer Resยท November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis